Sep 2026· Frontiers in Bioengineering and Biotechnology· Vol 14· 0 citations· 53 references
Medicine
TL;DR
Findings establish PGG-Zn@Cur as a microenvironment-responsive intra-articular platform that maintains cartilage matrix homeostasis and alleviates PI3K-AKT-associated apoptosis-related responses, offering a promising strategy for disease-modifying OA therapy.
Abstract
Introduction Osteoarthritis (OA) is a degenerative joint disease characterized by progressive degradation of the articular cartilage matrix, pain-related functional impairment, and a paucity of effective disease-modifying therapies. Curculigoside (Cur), a bioactive compound isolated from Curculigo orchioides, possesses anti-inflammatory and tissue-protective properties; however, its direct intra-articular application is hampered by insufficient local retention and limited sustained action. Methods We developed a Zn2+-coordinated pH-responsive hydrogel microsphere delivery system (PGG-Zn@Cur) based on gellan gum (GG) and γ-polyglutamic acid (γ-PGA) to enable localized intra-articular delivery of Cur. Its cytocompatibility and chondroprotective effects were evaluated in IL-1β-stimulated chondrocytes. Transcriptomic analysis was further performed to investigate the potential molecular mechanisms underlying its therapeutic effects. Results PGG-Zn@Cur exhibited excellent cytocompatibility and restored cartilage matrix metabolic homeostasis in IL-1β-stimulated chondrocytes, as evidenced by increased COL2A1 and ACAN expression and reduced MMP13, ADAMTS5, and iNOS levels. Transcriptomic analysis implicated PI3K-AKT signaling and apoptosis-related pathways in the chondroprotective effects mediated by PGG-Zn@Cur. Mechanistically, PGG-Zn@Cur suppressed PI3K-AKT pathway hyperactivation, downregulated Cleaved Caspase-3 and Bax expression, attenuated chondrocyte apoptosis, and alleviated cartilage degeneration. Discussion These findings establish PGG-Zn@Cur as a microenvironment-responsive intra-articular platform that maintains cartilage matrix homeostasis and alleviates PI3K-AKT-associated apoptosis-related responses, offering a promising strategy for disease-modifying OA therapy.
Osteoarthritis (OA) remains a leading cause of disability worldwide, with current therapies limited to symptomatic relief. In this study, we developed and evaluated a thermoresponsive hydrogel system based on N,N,N-trimethyl chitosan (TMC) for the sustained intra-articular delivery of capsaicin, an established analgesi...
Kyung Wook Kim, A. Padalhin, H. Ryu et al.· Biomaterials Research· 0 citations
In vivo evaluations in a rat calvarial defect model demonstrated that 24DOPA@M-PCL/β-TCP facilitated superior bone regeneration, characterized by elevated osteocalcin/osteopontin expression and reduced TRAP-positive osteoclast recruitment, underscore the significant clinical translational potential of this biomimetic,...
Yi-Xuan Lei, Jing-Jing Su, Wei-Xin Wang et al.· Regenerative Biomaterials· 0 citations
Postmenopausal osteoarthritis (OA) is a degenerative joint disorder characterized by cartilage erosion and subchondral bone loss, intensified by estrogen deficiency in menopausal women. Raloxifene (RLX), a selective estrogen receptor modulator, shows anti-inflammatory and chondroprotective potential but is associated w...
Atul Mourya, Hoshiyar Singh, Shristi Arya et al.· International Journal of Bio...· 0 citations
Hypertrophic scar (HS) is a fibrotic disorder caused by imbalanced tissue repair after skin injury. Its core features include persistent inflammation and excessive collagen deposition. Current clinical treatments are limited by poor efficacy, severe local adverse reactions, and low transdermal delivery efficiency of to...
Shi-Sheng Chen, Yuan-Yuan Hu, Hong-Ping Ge et al.· ACS Applied Materials and In...· 0 citations
Absolute uterine factor infertility (AUFI) remains untreatable with current assisted reproduction techniques. Although decellularized uterine extracellular matrix (dUECM) holds promise for uterine reconstruction, its clinical translation is limited by rapid degradation and poor angiogenic capacity. Herein, a dual-compo...